Jeffrey H Teckman

Jeffrey H Teckman

Saint Louis University

H-index: 46

North America-United States

About Jeffrey H Teckman

Jeffrey H Teckman, With an exceptional h-index of 46 and a recent h-index of 30 (since 2020), a distinguished researcher at Saint Louis University, specializes in the field of Liver Disease, Alpha-1-antitrypsin, Nutrition.

His recent articles reflect a diverse array of research interests and contributions to the field:

Biomarkers Associated with Future Severe Liver Disease in Children with Alpha-1-antitrypsin Deficiency

New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease

Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort

A Gastroenterologist’s Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care

Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease

Sa1546 INCREASED LIVER FIBROSIS IS THE KEY CLINICAL FACTOR ASSOCIATED WITH INCREASED FUTURE SEVERE LIVER DISEASE OUTCOMES IN A PROSPECTIVE COHORT OF ADULTS WITH ALPHA-1 …

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease

Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance

Jeffrey H Teckman Information

University

Position

___

Citations(all)

6401

Citations(since 2020)

2756

Cited By

4779

hIndex(all)

46

hIndex(since 2020)

30

i10Index(all)

90

i10Index(since 2020)

76

Email

University Profile Page

Google Scholar

Jeffrey H Teckman Skills & Research Interests

Liver Disease

Alpha-1-antitrypsin

Nutrition

Top articles of Jeffrey H Teckman

Biomarkers Associated with Future Severe Liver Disease in Children with Alpha-1-antitrypsin Deficiency

Gastro Hep Advances

2024/4/26

Jeffrey H Teckman
Jeffrey H Teckman

H-Index: 27

New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease

2024/3/22

Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort

Hepatology

2024/3/6

Jeffrey H Teckman
Jeffrey H Teckman

H-Index: 27

A Gastroenterologist’s Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care

2023/10/30

Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease

Journal of Gastroenterology and Hepatology

2023/6

Sa1546 INCREASED LIVER FIBROSIS IS THE KEY CLINICAL FACTOR ASSOCIATED WITH INCREASED FUTURE SEVERE LIVER DISEASE OUTCOMES IN A PROSPECTIVE COHORT OF ADULTS WITH ALPHA-1 …

Gastroenterology

2023/5/1

Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance

Hepatology Communications

2023/12/1

Change in Health-Related Quality of Life in Youth with Chronic Hepatitis B Living in North America: A 5-Year Cohort Study

Journal of pediatric gastroenterology and nutrition

2023/12/1

Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease

Hepatology Communications

2023/11/1

Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency

New England Journal of Medicine

2022/8/11

Alpha-1 antitrypsin deficiency liver disease

2022/8/1

Anandini Suri
Anandini Suri

H-Index: 2

Jeffrey H Teckman
Jeffrey H Teckman

H-Index: 27

Perfusion Regulated Organ Therapeutics with Enhanced Controlled Testing

2022/7/14

Lessons Learned From Children Enrolled Into the Hepatitis B Virus Research Network Multi-Center Prospective Study

Journal of pediatric gastroenterology and nutrition

2022/4/1

Alpha‐1‐Antitrypsin Deficiency

2022/3/1

Novel NMP split liver model recapitulates human IRI and demonstrates ferroptosis modulators as a new therapeutic strategy

Pediatric transplantation

2022/3

The inflammatory cytokine profile associated with liver damage is broader and stronger in patients with chronic hepatitis B compared to patients with acute hepatitis B

The Journal of infectious diseases

2022/2/1

Changes in serum hepatitis B surface and e antigen, interferon‐inducible protein 10, and aminotransferase levels during combination therapy of immune‐tolerant chronic hepatitis B

Hepatology

2022/9/1

Precore and basal core promoter hepatitis B virus (HBV) variants are present from a young age and differ across HBV genotypes

Hepatology

2021/5

See List of Professors in Jeffrey H Teckman University(Saint Louis University)